Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Patent cliff losses set to cost pharma $65bn by 2019

Lilly, AZ and Otsuka to be hit hard, says GlobalData

- PMLiVE

NICE backs Pfizer drug in kidney cancer

Inlyta near end of two-year struggle for recommendation

- PMLiVE

Germany’s IQWiG delivers bad news for Bayer’s Eylea

Says drug provides no additional benefit over Novartis’ rival Lucentis in eye condition

- PMLiVE

Roche and Exelixis file melanoma duo in US

Combination of cobimetinib and Zelboraf improved progression-free survival by 9.9 months

- PMLiVE

Dr Thomas Werner joins RIEMSER Pharma advisory board

Former GSK Germany head will support its international expansion

- PMLiVE

Merck names head of strategic communications

Julie Gerberding will also have responsibility for global public policy and population health

- PMLiVE

Cyramza gets FDA green light in lung cancer

Drug steadily being approved for further uses

- PMLiVE

Novartis’ Afinitor fails frontline breast cancer trial

Drug already approved to treat HER2-negative breast cancer

- PMLiVE

BIA chooses Antibiotic Research UK as charity of the year

O'Neill Commission warns on global impact of infections

Zealand’s Arvind Hundal steps down as chief business officer

She leaves after five years with the Danish biotech company

- PMLiVE

Taking health issues to the classroom

It’s time pharma looked to the classroom to improve the nation’s health

healthcare data technology

Pharma must ‘get on-board with digital health’ to be more patient-focused

But it's not about us - it's about what patients want, says BMI Healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links